Su An (苏安)苏安
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 江苏万邦生化医药股份有限公司Chinese legal name: 江苏万邦生化医药股份有限公司
主要成分Active Ingredients
- 环磷腺苷葡胺Huanlin Xiangan Puan
药物知识说明
环磷腺苷葡胺是一种在国家药监局注册认定的药品。该药品含有环磷腺苷葡胺-ab9f1478等成分。
该药品关联的活性成分包括：环磷腺苷葡胺Huanlin Xiangan Puan。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：江苏万邦生化医药股份有限公司Chinese legal name: 江苏万邦生化医药股份有限公司。
您可以探索含有相同成分的其他药品：环磷腺苷葡胺-ab9f1478成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 苏安) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 环磷腺苷葡胺Huanlin Xiangan Puan.
Manufacturers recorded for this product: 江苏万邦生化医药股份有限公司Chinese legal name: 江苏万邦生化医药股份有限公司.
Explore other medicines containing the same ingredient: 环磷腺苷葡胺 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 苏安Recorded Chinese name: 苏安
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 30mg。30 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 江苏万邦生化医药股份有限公司Chinese legal name: 江苏万邦生化医药股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20050478
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20050478
Manufacturer
Chinese legal name: 江苏万邦生化医药股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20050478
生产企业
江苏万邦生化医药股份有限公司(国产)
适应症
用于心力衰竭、心肌炎、病窦综合症、冠心病及心肌病，也可用于心律失常的辅助治疗。
用法用量
1.静脉滴注:加入200~500ml 5%葡萄糖注射液溶解后静脉滴注，一日一次，一次60~180mg。|2.静脉推注:加入20~40ml 25%或10%葡萄糖注射液溶解后缓慢静脉推注，一日一次，一次90mg。
不良反应
偶见心悸、心慌、头晕等症状。
禁忌
1.对药物中任一成分过敏者。|2.本品禁与氨茶碱同时静脉给药。
注意事项
1.滴注不应太快，用量在150mg以上应在90分钟以上滴完。|2.如遇心悸、心慌，应停止用药，停药后症状自行消失。
贮藏
遮光，密闭保存。
规格
30mg。
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.